Iocarmic acid
Clinical data | |
---|---|
Trade names | Dimer-X |
Other names | 3-[[6-[[3-Carboxy-2,4,6-triiodo-5-(methylcarbamoyl)phenyl]amino]-6-oxohexanoyl]amino]-2,4,6-triiodo-5-(methylcarbamoyl)benzoic acid |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.030.771 |
Chemical and physical data | |
Formula | C24H20I6N4O8 |
Molar mass | 1253.871 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Iocarmic acid (trade name Dimer-X) is a pharmaceutical drug used as an iodinated contrast medium for X-ray imaging in the 1970s and 80s. Uses included imaging of the uterus and fallopian tubes. It was applied in form of its salt, meglumine iocarmate.[1][2]
It is not known to be marketed anywhere in the world in 2021.
References
[edit]- ^ Schütte HE (1982). "Comparative study: Endografine (diatrizoate), Vasurix polyvidone (acetrizoate), Dimer-X (iocarmate) and Hexabrix (ioxaglate) in hysterosalpingography". Diagnostic Imaging. 51 (6): 277–83. PMID 7173007.
- ^ Van Dellen JR, Lipschitz R (October 1973). "Meglumine iocarmate (Dimer-X) ventriculography". Clinical Radiology. 24 (4): 449–52. doi:10.1016/s0009-9260(73)80146-1. PMID 4621055.